Most cited papers from Teva Pharmaceuticals (Ireland)
Teva Pharmaceuticals (Ireland)
What are the most cited papers from Teva Pharmaceuticals (Ireland)?
The most cited paper from Teva Pharmaceuticals (Ireland) is "Rapid HCV-RNA Decline With Once Daily TMC435: A Phase I Study in Healthy Volunteers and Hepatitis C Patients" (Henk W. Reesink, Gregory C. Fanning, Khalid Abou Farha et al., 2009), with 156 citations. Next come "Rapid Viral Response of Once-Daily Tmc435 plus Pegylated Interferon/Ribavirin in Hepatitis C Genotype-1 Patients: A Randomized Trial" (66) and "A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites" (61).
Showing 15 of 15 papers.Every paper is listed.
Most cited papers, sortable by citations and release date
Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or
Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation;
retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown.
How the lists are chosen.